chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Rapid heart beat; Chest pain; arm pain .pain 8/10; No appetite; Shortness of breath; Headache; Soreness in the arm  I received the vaccine; Numbness in my face; Did not sleep well last night; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Shortness of breath), HEART RATE INCREASED (Rapid heart beat), CHEST PAIN (Chest pain), PAIN IN EXTREMITY (arm pain .pain 8/10) and HYPOAESTHESIA (Numbness in my face) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J202A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (no medical history provided).    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On 12-Jan-2021, the patient experienced HYPOAESTHESIA (Numbness in my face), INSOMNIA (Did not sleep well last night), HEADACHE (Headache) and INJECTION SITE PAIN (Soreness in the arm  I received the vaccine). On 13-Jan-2021, the patient experienced DYSPNOEA (Shortness of breath), CHEST PAIN (Chest pain), PAIN IN EXTREMITY (arm pain .pain 8/10) and DECREASED APPETITE (No appetite). On an unknown date, the patient experienced HEART RATE INCREASED (Rapid heart beat). The patient was treated with IBUPROFEN (MOTRIN [IBUPROFEN]) at an unspecified dose and frequency and ALPRAZOLAM (XANAX) at an unspecified dose and frequency. On 12-Jan-2021, HYPOAESTHESIA (Numbness in my face) had resolved. At the time of the report, DYSPNOEA (Shortness of breath), HEART RATE INCREASED (Rapid heart beat), CHEST PAIN (Chest pain), PAIN IN EXTREMITY (arm pain .pain 8/10), INSOMNIA (Did not sleep well last night), DECREASED APPETITE (No appetite), HEADACHE (Headache) and INJECTION SITE PAIN (Soreness in the arm  I received the vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       no concomitant history provided patient has taken treatment with prescription; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start dates of the events, a causal relationship cannot be excluded.
Patient was given bivalent, but had not had the primary series of pfizer or any covid vaccine.
This is a spontaneous report from a nurse referring to her 41 year old husband. The pt received his 1st Lymerix shot on 6/7/99 and on the same day, he experienced a sore left arm which resolved in 2 days. On 6/9/99, he experienced paresthesias (tingling and numbness) in his left arm. He saw a physician and had an electromyogram performed on 7/1/99 which revealed carpal tunnel syndrome of the left wrist. This was treated with a wrist splint. On 6/7/99, the received the 2nd Lymerix shot in his right arm, with no untoward affects. The most recent information received on 7/9/99, reports the paresthesia of the left arm and carpal tunnel syndrome on the left wrist are ongoing.
nonproductive cough, chills, shortness of breath, loss of taste, loss of smell, nasal congestion, post nasal drainage, sneezing, itchy eyes runny nose, ear fullness. starting on 11/5/2021
shingles; This initial spontaneous report was received from a lawyer regarding a case in litigation referring to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions or concomitant medications were not reported. In or around 2016, the patient was inoculated with zoster vaccine live (ZOSTAVAX) (lot#, expiration date, dosage, route of administration and anatomical location were not provided) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster). On an unspecified date, shortly after receiving zoster vaccine live (ZOSTAVAX) vaccine, the patient (pt) suffered shingles. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the pt's symptoms have resulted in physical limitations and seriousness of the pt's condition. As a result of the zoster vaccine live (ZOSTAVAX), the pt sustained severe and permanent personal injuries. Further, as a tragic consequence, the pt suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result, the pt suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages. The outcome of shingles was considered to be not recovered. The reporter considered shingles to be related to Zoster Vaccine Live (ZOSTAVAX).  Upon internal review, the event of shingles was determined to be disabling.
Sore arm at injection point Gradual fever culminating at 102.6 at 10pm on 3/13 Loss of appetite and extreme fatigue Took 1 motto and went to sleep at 5pm - woke at 10pm - fitful sleep until noon 3/14 Fever continued through 3/14 - 100.2 at noon through 99 at 5pm - light fatigue throughout the day 3/15 - completely back to normal energy and temperature (yay!)
she went into panic mode; She said that it started to swell and itch and was lower than the original place; red circle rash is larger/is further down on her arm; she did have black and blue mark; She said that she had a huge bump that was itchy and the bump looked like it had spread in height and circumference; redness/redness at the injection site; bump at the injection site; allergic reaction; This is a spontaneous report from a contactable consumer (patient).   A 74-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot number was not reported), via an unspecified route of administration on 17Feb2021 as dose 1, single for COVID-19 immunisation.  Medical history included known allergies to latex, sporins, chromium. The patient's concomitant medications were not reported.  Patient was given the shot on 17Feb2021 and she was well on that day. On the next day, 18Feb2021, she had a little redness and bump at the injection site. It got a little bit larger on 19Feb2021. She said that then it got a little flatter, but the bump did not quite go away.  Then on Wednesday, 24Feb2021, she had a huge flare up. Her huge bump was itchy and the bump looked like, it had spread in height and circumference. She had a telehealth visit with her doctor. He said that it looked like an allergic reaction and she was supposed to take Benadryl and hydrocortisone cream 1%. The following day it got better and by Sunday, on 28Feb2021 she felt as though she did not need the medication anymore, but she had a little bit of black and blue mark. On Monday, 01Mar2021 it started to itch a little bit, redness returned, and was getting bigger, and Tuesday, on 02Mar2021 it started all over again.  Also, started to swell and itch and that was lower than the original place, travelled down her arm.  On Wednesday, 03Mar2021, she went into panic mode. She returned to the doctor, he informed, that it was an allergic reaction. He said that she should not get the second dose or if she did, then it would have to be under a medical setting, or else may have another reaction and would be more difficult to handle. It was reported, at the time of report, all of this is 2 weeks old. Therapeutic measures in response to the events included benadryl and hydrocortisone cream . The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Information has been received from a nurse concerning a 15 year old female who on an unspecified date was vaccinated intramuscularly with the first dose of Gardasil. Subsequently, one day post vaccination, the patient developed a red, slightly raised area around the injection site. Unspecified medical attention was sought. It was reported that the patient improved after two days are was doing fine. Additional information has been requested. This is one of two reports from the same source.
Patient received 1st dose on 01/18/2021, returned to clinic and presented for 2nd dose. Date written on 2nd dose Immunization 66form was 1/1/2021. Patient received 2nd dose of Moderna on 02/04/2021.
covid; covid; This is a solicited report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. Other Case identifier(s): US-ABBVIE-4178192.  A 64-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 07Oct2022 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 64 years intramuscular for covid-19 immunisation; BNT162b2 (BNT162B2), as dose 3 (booster), single (Batch/Lot number: unknown) intramuscular for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation; adalimumab (HUMIRA), (Batch/Lot number: unknown) at 40 mg (40 mg (citrate free)), subcutaneous for rheumatoid arthritis, crohn's disease. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 10Oct2022, outcome "recovering" and all described as "covid". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (10Oct2022) Positive. The action taken for adalimumab was unknown. The reporter's causality for the event(s) of covid with Pfizer BioNTech COVID-19 vaccine (Tozinameran) was Reasonable Possibility.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5, BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: As there is limited information in the case provided, the causal association between the reported events with the suspect drugs BNT162B2 and BNT162b2, BNT162b2 omi ba.4-5 cannot be excluded. The case will be reassessed once new information is available.
Pt tested positive for COVID 5/17/21. Completed COVID vaccine series 1/18/21. Sore throat/headache onset 5/12. Reports negative PCR since then, but we have no documentation of this. Loss of taste/smell 5/17 followed by positive PCR. Multiple positive household members.
Pfizer-BioNTech COVID-19 Vaccine EUA Severe headache & migraines without relief for approximately 72 hours.
The shot gave my mother a blood disorder that killed her; This case was reported by a consumer via interactive digital media and described the occurrence of blood disorder in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced blood disorder (serious criteria death). On an unknown date, the outcome of the blood disorder was fatal. The reported cause of death was blood disorder.   The reporter considered the blood disorder to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 26-Jun-2022 Reporters comment: The case was reported by patient's child via interactive digital media. The shot gave the patient a blood disorder that killed her. The vaccine for them killed the patient. Additional Supportive Information: The follow up was not possible as no contact details were available.; Reported Cause(s) of Death: Blood disorder
Soreness and lunp at injection site (even 4 days later). Tingling in arm that received injection.  Chills and weakness.
pt recv vax 19SEP97 & that same day pt reportedly screamed for 1hr p/inj;also the pt exp fever (unspecified), inconsolable crying & irritability for 19hr p/inj;
Pt vaccinated with DTP developed a runny nose, cough, then wheezing requiring bronchodilator & organidin for 10-14days. Received 2nd DTP developed same symptoms as before requiring treatment for 5-7 days.
Pulmonary fibrosis; Did not help us one bit, hurt us actually; still got Covid; long term COVID; This spontaneous case was reported by a nurse and describes the occurrence of PULMONARY FIBROSIS (Pulmonary fibrosis) in a male patient of an unknown age who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7140C) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 08-Sep-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced PULMONARY FIBROSIS (Pulmonary fibrosis) (seriousness criterion medically significant) and POST-ACUTE COVID-19 SYNDROME (Did not help us one bit, hurt us actually; still got Covid; long term COVID). At the time of the report, PULMONARY FIBROSIS (Pulmonary fibrosis) and POST-ACUTE COVID-19 SYNDROME (Did not help us one bit, hurt us actually; still got Covid; long term COVID) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported.  On 02-Feb-2021, the patient had first dose, lot: 012M20A. Patient took all vaccines of Moderna.  Patient visited pulmonologist since his case was severe.  No treatment medication was reported.  Company Comment This spontaneous case concerns a male patient of an unknown age with no medical history reported who experienced the unexpected medically significant seriousness criteria event of Pulmonary fibrosis and the unexpected event of post-acute Covid-19 syndrome unknown days after a. dose of mRNA-1273 BIVALENT .222 vaccine. Concomitant medication details nor Treatment details were reported At the time of the report, the outcome of the events were unknown.    The benefit-risk relationship of mRNA-1273 BIVALENT .222 vaccine is not affected by this report.   This case was linked to US-MODERNATX, INC.-MOD-2023-748042, US-MODERNATX, INC.-MOD-2023-747954 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-748042:Case for Wife US-MODERNATX, INC.-MOD-2023-747954:Invalid case
pt recv vax & devel an inj site rxn characterized by redness & swelling w/pain radiating from site down the arm;pt has recv pneumococcal vax in the past;this is one of ten patients who exp above rxn p/vax;
administered an expired Twinrix; This case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a 60-year-old female patient who received HAB (Twinrix adult) (batch number 57E3G, expiry date 28th February 2022) for prophylaxis.   Co-suspect products included hepatitis A and hepatitis B vaccine pre-filled syringe device (Twinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 10th March 2022, the patient received Twinrix adult and Twinrix Pre-Filled Syringe Device. On 10th March 2022, unknown after receiving Twinrix adult and Twinrix Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.     This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional information was provided as follows: Pharmacist called in to inquire and report about expired Twinrix dose. The reporter reported that they inadvertently administered an expired Twinrix dose to a patient. The reporter consented to follow up.
pt recvd vax & 2months p/vax was found to have antigenemia;
Extreme pain in all of body and trouble breathing.  After a day the pain in muscles and joints  stopped but I had severe breathing  problems.  Walking from one room to another my breathing would become labored.  Going up steps slowly - when I got to the top I was gasping for air.  When I take a deep breath I have pain in my chest.  Even the smallest tasks can make breathing difficult so I sit down until the breathing calms down.  Dr. did a test on my lungs and said my lungs are that of a 100 yr old woman.  When I was 63  he checked my lungs and said they were not bad - bout 70 yrs old and I smoked at that time.  I have not smoked in closed to 4 years now.
within 24 hours had unusual tongue sensation, then left side of face numbness, eyelid swelling,  left sided facial droop. Diagnosed with Bell's Palsy at office visit 3/31/21
night sweats.; lethargic for 2 weeks after receiving the first dose; feeling wipe out; felt nauseous; chills during the day and night; fever; This spontaneous case was reported by a patient and describes the occurrence of HYPERHIDROSIS (night sweats.), LETHARGY (lethargic for 2 weeks after receiving the first dose), FATIGUE (feeling wipe out), NAUSEA (felt nauseous) and CHILLS (chills during the day and night) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 immunisation. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Shellfish allergy. Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for Runny nose and Allergy, AMLODIPINE BESILATE, BENAZEPRIL HYDROCHLORIDE (AMLODIPINE BENAZEPRIL), LEVOTHYROXINE SODIUM (LEVOTHYROXIN), METOPROLOL, CELECOXIB (CELEBREX), PARACETAMOL (TYLENOL) and PANTOPRAZOLE for an unknown indication.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, the patient experienced HYPERHIDROSIS (night sweats.), LETHARGY (lethargic for 2 weeks after receiving the first dose), FATIGUE (feeling wipe out), NAUSEA (felt nauseous), CHILLS (chills during the day and night) and PYREXIA (fever). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, HYPERHIDROSIS (night sweats.), LETHARGY (lethargic for 2 weeks after receiving the first dose), FATIGUE (feeling wipe out), NAUSEA (felt nauseous), CHILLS (chills during the day and night) and PYREXIA (fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       second dose scheduled on 12May2021
The pt developed a fever of 103.5 and had a brief seizure lasting 4 minutes.
No adverse effects reported; Multiple patients were vaccinated with improperly stored ROTATEQ on multiple dates; Information has been received from a medical assistant concerning a patient of unknown age, gender and race. The patient's medical history, drug allergies, previously drug reactions, concurrent conditions and concomitant medications were not reported.  On 30-JAN-2019, the patient was vaccinated with an improperly stored dose of Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) orally for prophylaxis (lot number N034400 with expiration date in 10-MAY-2019) (strength and anatomical location were not provided).  The Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) was stored at an unknown temperature for an unknown time frame. There was a previous temperature excursion and the call was because of a data logger.  No adverse effects reported.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1906USA011434: US-009507513-1907USA001848: US-009507513-1907USA001847: US-009507513-1907USA001849: US-009507513-1907USA001793: US-009507513-1907USA001794: US-009507513-1907USA001795: US-009507513-1907USA001797: US-009507513-1907USA001798: US-009507513-1907USA001799: US-009507513-1907USA001800: US-009507513-1907USA001801: US-009507513-1907USA001802: US-009507513-1907USA001803: US-009507513-1907USA001804: US-009507513-1907USA001805: US-009507513-1907USA001806: US-009507513-1907USA001807: US-009507513-1907USA001808: US-009507513-1907USA001809: US-009507513-1907USA001810: US-009507513-1907USA001811: US-009507513-1907USA001812: US-009507513-1907USA001813: US-009507513-1907USA001814: US-009507513-1907USA001815: US-009507513-1907USA001816: US-009507513-1907USA001817: US-009507513-1907USA001818: US-009507513-1907USA001819: US-009507513-1907USA001820: US-009507513-1907USA001821: US-009507513-1907USA001822: US-009507513-1907USA001823: US-009507513-1907USA001824: US-009507513-1907USA001825: US-009507513-1907USA001826: US-009507513-1907USA001827: US-009507513-1907USA001828: US-009507513-1907USA001829: US-009507513-1907USA001830: US-009507513-1907USA001831: US-009507513-1907USA001832: US-009507513-1907USA001833: US-009507513-1907USA001834: US-009507513-1907USA001835: US-009507513-1907USA001836: US-009507513-1907USA001837: US-009507513-1907USA001838: US-009507513-1907USA001839: US-009507513-1907USA001840: US-009507513-1907USA001841: US-009507513-1907USA001842: US-009507513-1907USA001843: US-009507513-1907USA001844: US-009507513-1907USA001845: US-009507513-1907USA001846: US-009507513-1907USA000952: US-009507513-1907USA000953: US-009507513-1907USA000954: US-009507513-1907USA000959: US-009507513-1907USA000962: US-009507513-1907USA000963: US-009507513-1907USA000964: US-009507513-1907USA000965: US-009507513-1907USA000966: US-009507513-1907USA000967: US-009507513-1907USA000968: US-009507513-1907USA000969: US-009507513-1907USA000970: US-009507513-1907USA000988: US-009507513-1907USA000989:
March 26, 2021: One week to the day after receiving my second dose of the Pfizer COVID19 vaccine, my right eye suddenly had double vision and facial pain behind the right eye and all around the right eye (forehead, right temple, around to under the right eye on the cheek).  The right eye would not move correctly.    March 27, 2021: I went to see Optometrist.  He performed an eye exam with dilation and stated that the right eye was slow to track, and that the nerve behind the right eye was inflamed.  He recommended blood work, CT scan, and an MRI.    March 27, 2021 ? March 28, 2021: We went to ER at 9:00pm.  After waiting six hours, I finally was able to see an ER doctor.  No medical history was taken.  No bloodwork was done.  ER Dr performed a CT scan as Dr requested.  CT scan w/o contrast showed no masses or hemorrhages.  ER suggested to follow-up with Nuerology.  March 29, 2021: Went to Neurologist and he examined me.  He called in another Dr for a second opinion.  They stated that it may be a possible cranial nerve palsy and ordered multiple MRIs.    March 29, 2021: The earliest MRI appointment available was April 7, 2021.  Scheduled the MRI.  April 1, 2021: Had blood drawn at lab as Dr requested.  April 2, 2021: Two weeks from the day of COVID19 vaccine #2, my right eyelid would not open at all and the pain was getting worse.  April 5, 2021: Went to ER at 4:30am.  Triage nurse sent me straight to an ER room and within minutes an ER doctor was there.  Within 15 minutes after seeing the ER doctor, a Neurologist was examining me.  The nuero doctor was very thorough.  While waiting for the MRI, other neurologists and residents also examined me.  MRI scans with and without contrast were performed.  MRI images were clear ? no tumors, no aneurisms, and no stroke.  They concluded that it was a micro-vascular injury to cranial nerve #3.  (Similar to the Bells Palsy that I had in 2015.)  They prescribed gabapentin to help calm the nerve pain.  Follow-up will be with nuero-ophthalmologist.